Hugo Quiroz–Mercado

Twelve-month safety of intravitreal injections of bevacizumab (Avastin®): results of the Pan-American Collaborative Retina Study Group (PACORES)

Lihteh Wu, María Ana Martinez-Castellanos, Hugo Quiroz–Mercado et al. · Graefe s Archive for Clinical and Experimental Ophthalmology · 2007 · 457 citations

Medicine, Ophthalmology, Surgery +16

Acute endophthalmitis following intravitreal triamcinolone acetonide injection

Darius M. Moshfeghi, Peter K. Kaiser, Ingrid U. Scott et al. · American Journal of Ophthalmology · 2003 · 399 citations

Medicine, Ophthalmology, Surgery +9

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema

J. Fernando Arévalo, Jans Fromow-Guerra, Hugo Quiroz–Mercado et al. · Ophthalmology · 2007 · 337 citations · Full text

Medicine, Ophthalmology, Pharmacotherapy +13

LONG-TERM EFFECT OF ANTIANGIOGENIC THERAPY FOR RETINOPATHY OF PREMATURITY Up to 5 Years of Follow-up

María Ana Martinez-Castellanos, Shulamit Schwartz, Myriam Lucía Hernández-Rojas et al. · Retina · 2012 · 118 citations

Medicine, Ophthalmology, Pediatrics +13

Short-term outcome after intravitreal ranibizumab injections for the treatment of retinopathy of prematurity

María Ana Martinez-Castellanos, Shulamit Schwartz, Gerardo García‐Aguirre et al. · British Journal of Ophthalmology · 2012 · 100 citations

Medicine, Ophthalmology, Pediatrics +17